Telmisartan
Links shared publicly online about this topic
FDA panel reviews telmisartan
theheart.org — “UPDATED // The panel grappled with noninferiority margins and other statistical issues during the daylong hearing, and while it wouldn't give a wide indication for use in all high-risk cardiovascular patients, it felt that telmisartan is a good option for patients intolerant to the ACE inhibitor ramipril.” View full resource at theheart.org
Most Recently Shared on July 29, 2009 at 9:39 pm By:
heartwire: No to expanded indication for telmisartan, except in ramipril-intolerant patients, says FDA.. http://bit.ly/HGHJa
New telmisartan indication
theheart.org — “The drug can now be used to reduce the risk of MI, stroke, or death from cardiovascular causes in patients 55 years of age or older who are intolerant to ACE inhibitors but at high risk for cardiovascular events.” View full resource at theheart.org
Most Recently Shared on October 19, 2009 at 5:46 pm By:
heartwire: Expanded indication for telmisartan http://bit.ly/NGLbG
Endocrinology Article | Telmisartan therapy
mdlinx.com — “Reduction of circulating superoxide dismutase activity in type 2 diabetic patients with microalbuminuria and its modulation by telmisartan therapy” View full resource at mdlinx.com
Most Recently Shared on August 5, 2011 at 4:13 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Reduction of circulating superoxide dismutase activity in type 2 diabetic patients with microalbuminuria a... http://bit.ly/qLOdbw #endo
Symposier - FDA Approves MICARDIS® (Telmisartan)
symposier.com — “Uploaded and Shared in Youtube by:BusinessWire Prof. Thomas Unger, Germany (Video: Business Wire) Permalink: http://www.businesswire.com...” View full resource at symposier.com
Most Recently Shared on December 2, 2009 at 4:58 am By:
Symposier Cardiology Cardiology and Health Business
FDA Approves MICARDIS® (Telmisartan) -->http://bit.ly/8Oynvf #red WAIDSDAY
Telmisartan (Micardis) Drug Information by MedicineNet.com
medicinenet.com — “Telmisartan (micardis) is an arb prescribed for the treatment of high blood pressure and the prevention of heart attack, stroke, and cardiovascular events in patients at risk.” View full resource at medicinenet.com
Most Recently Shared on January 7, 2010 at 6:45 pm By:
MedicineNet: telmisartan, Micardis http://bit.ly/64aggw Full http://bit.ly/7AQcW1
FDA Approves Twynsta (telmisartan/amlodipine) for Hypertension
drugs.com — “Twynsta (telmisartan/amlodipine) is used to treat hypertension. Includes Twynsta side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 24, 2009 at 4:45 am By:
FDA Approves Twynsta (telmisartan/amlodipine) for Hypertension - http://bit.ly/21Fifg
Major European Regulatory Milestone In Cardiovascular Protection For MICARDIS(R) (telmisartan)
medicalnewstoday.com — “Boehringer ingelheim announced that the european commission has approved micardis® (telmisartan) for the reduction of cardiovascular morbidity in patients with: i. manifest atherothro” View full resource at medicalnewstoday.com
Most Recently Shared on November 30, 2009 at 11:13 am By:
MedicalNewsToday: Major European Regulatory Milestone In Cardiovascular Protection For: http://bit.ly/4WXeiu Full http://bit.ly/8vkJa9
Sodium chloride supplementation reduced albumin excretion rate response to telmisartan
endocrinetoday.com — “The albumin excretion rate response to telmisartan with or without hydrochlorothiazide was blunted by sodium chloride supplementation in patient” View full resource at endocrinetoday.com
Most Recently Shared on September 1, 2009 at 2:52 pm By:
Sodium chloride supplementation reduced albumin excretion rate response to telmisartan: http://ow.ly/nA9x
Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk
instapaper.com — “Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk” View full resource at instapaper.com
Most Recently Shared on March 2, 2011 at 4:37 pm By:
Yvo Sijpkens MD Nephrologist, Physician, Doctor, and Internist
No support for dual RAS-blocking therapy over monotherapy in high–risk patients with low eGFR or albuminuria: http://bit.ly/gRG0xt
Telmisartan Metoprolol Succinate (Newest posts first) - The People's Medicine Community
prescriptiondrug-info.com — “my blood pressure used to be 150 90 or 140 90 The doctor prescribed me Telmisartan BP 40mg Metoprolol Succinate USP 25 mg about 3 months back After 2 months BP came down to 120 80 but now for the last one week I am facing severe gas problem in stomach chest On 17 05 2011 evening I had severe pain an (Newest posts first)” View full resource at prescriptiondrug-info.com
Most Recently Shared on May 23, 2011 at 3:35 am By:
" my blood pressure used to be 150/90 or 140/90. The doctor prescribed me Telmisartan BP 40mg & Metoprolol Suc http://PD0.US/F217923
Cardiology Medical News about Blood Pressure Monitoring, Ambulatory Hypertension Primary Health Care telmisartan
mdlinx.com — “Effects of telmisartan on office- and 24-hour ambulatory blood pressure: an observational study in hypertensive patients managed in primary care” View full resource at mdlinx.com
Most Recently Shared on January 19, 2010 at 9:30 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Cardio: Effects of telmisartan on office- and 24-hour ambulatory blood pressure: an observational study in hypertensive http://url4.eu/1AAbk
Family Med Medical News about Blood Pressure Monitoring, Ambulatory Hypertension Primary Health Care telmisartan
mdlinx.com — “Effects of telmisartan on office- and 24-hour ambulatory blood pressure: an observational study in hypertensive patients managed in primary care” View full resource at mdlinx.com
Most Recently Shared on January 19, 2010 at 9:22 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Med: Effects of telmisartan on office- and 24-hour ambulatory blood pressure: an observational study in hypertensive pa http://url4.eu/1AAQK
Internal Med Medical News about Blood Pressure Monitoring, Ambulatory Hypertension Primary Health Care telmisartan
mdlinx.com — “Effects of telmisartan on office- and 24-hour ambulatory blood pressure: an observational study in hypertensive patients managed in primary care” View full resource at mdlinx.com
Most Recently Shared on January 19, 2010 at 10:17 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Int Med: Effects of telmisartan on office- and 24-hour ambulatory blood pressure: an observational study in hypertensiv http://url4.eu/1ABhs
Influence of telmisartan on insulin response after glucose loading in obese patients with hypertension: ARB Trial of hypertension in obese patients with hyperinsulinemia assessed by oral glucose tolerance test (ATHLETE)
ntkinstitute.org — “Influence of telmisartan on insulin response after glucose loading in obese patients with hypertension: ARB Trial of hypertension in obese patients with hyperinsulinemia assessed by oral glucose tolerance test (ATHLETE)” View full resource at ntkinstitute.org
Most Recently Shared on August 5, 2011 at 12:17 pm By:
James Underberg Doctor, Internist, and Physician
#telmisartan effect on #insulin response after #glucose loading in #obese patients with #hypertension: #ATHLETE Trial http://bit.ly/mWIRCY
Telmisartan, a dual ARB/partial PPAR-γ agonist, protects myocardium from ischaemic reperfusion injury in experimental diabetes - Goyal - 2011 - Diabetes, Obesity and Metabolism - Wiley Online Library
onlinelibrary.wiley.com — “Telmisartan, a dual ARB/partial PPAR-γ agonist, protects myocardium from ischaemic reperfusion injury in experimental diabetes - Goyal - 2011 - Diabetes, Obesity and Metabolism - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on April 22, 2011 at 6:34 pm By:
Endocrinology Wisdom OW Health
Telmisartan, a dual ARB/partial PPARâ€*γ agonist, protects myocardium from ischaemic reperfusion injury in expe... http://bit.ly/heu7il
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
